Marshall Machines Ltd
NSE:MARSHALL
Marshall Machines Ltd
NSE:MARSHALL
Price:
3.64
INR
Market Closed
Market Cap:
₹87m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Marshall Machines Ltd
NSE:MARSHALL
|
IN |
|
C
|
Coastal Roadways Ltd
BSE:520131
|
IN |
|
B
|
Biogen Inc
LSE:0R1B
|
US |
|
M
|
Millennium Group International Holdings Ltd
NASDAQ:MGIH
|
HK |
|
Z
|
Zhejiang Huakang Pharmaceutical Co Ltd
SSE:605077
|
CN |
|
R
|
RHT Health Trust
SGX:RF1U
|
SG |
|
J
|
Just Group PLC
LSE:JUST
|
UK |
Balance Sheet
Balance Sheet Decomposition
Marshall Machines Ltd
Marshall Machines Ltd
Balance Sheet Decomposition is not available for
Marshall Machines Ltd
Marshall Machines Ltd
Balance Sheet
Marshall Machines Ltd
Marshall Machines Ltd
Currency: INR
| Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
8
|
7
|
13
|
19
|
39
|
42
|
45
|
23
|
3
|
3
|
4
|
|
| Cash |
0
|
0
|
0
|
0
|
39
|
42
|
45
|
23
|
3
|
3
|
4
|
|
| Cash Equivalents |
8
|
7
|
13
|
19
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
4
|
1
|
|
| Total Receivables |
54
|
57
|
56
|
95
|
144
|
170
|
140
|
117
|
180
|
284
|
353
|
|
| Accounts Receivables |
39
|
50
|
47
|
82
|
114
|
124
|
140
|
117
|
180
|
284
|
353
|
|
| Other Receivables |
15
|
8
|
9
|
12
|
30
|
47
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
299
|
397
|
391
|
367
|
383
|
399
|
458
|
480
|
504
|
504
|
426
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
37
|
26
|
21
|
30
|
158
|
|
| Total Current Assets |
361
|
461
|
460
|
481
|
566
|
612
|
680
|
645
|
713
|
825
|
942
|
|
| PP&E Net |
143
|
125
|
113
|
149
|
165
|
383
|
460
|
618
|
574
|
534
|
489
|
|
| Intangible Assets |
1
|
2
|
12
|
12
|
63
|
81
|
69
|
65
|
51
|
41
|
116
|
|
| Note Receivable |
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
13
|
17
|
|
| Other Long-Term Assets |
21
|
7
|
7
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
527
N/A
|
596
+13%
|
594
0%
|
650
+10%
|
796
+22%
|
1 078
+35%
|
1 211
+12%
|
1 330
+10%
|
1 353
+2%
|
1 413
+4%
|
1 563
+11%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
116
|
148
|
146
|
184
|
184
|
161
|
199
|
211
|
249
|
381
|
336
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
| Short-Term Debt |
5
|
0
|
0
|
0
|
0
|
171
|
188
|
208
|
248
|
225
|
205
|
|
| Current Portion of Long-Term Debt |
155
|
197
|
186
|
179
|
215
|
87
|
42
|
53
|
59
|
49
|
45
|
|
| Other Current Liabilities |
86
|
76
|
92
|
119
|
117
|
126
|
175
|
155
|
182
|
146
|
64
|
|
| Total Current Liabilities |
361
|
421
|
423
|
482
|
516
|
545
|
604
|
627
|
738
|
803
|
652
|
|
| Long-Term Debt |
76
|
83
|
75
|
59
|
74
|
84
|
137
|
129
|
95
|
179
|
134
|
|
| Deferred Income Tax |
2
|
0
|
0
|
2
|
19
|
34
|
30
|
59
|
51
|
30
|
11
|
|
| Other Liabilities |
8
|
8
|
8
|
9
|
9
|
29
|
28
|
25
|
10
|
6
|
5
|
|
| Total Liabilities |
446
N/A
|
512
+15%
|
506
-1%
|
552
+9%
|
618
+12%
|
693
+12%
|
798
+15%
|
840
+5%
|
894
+6%
|
1 018
+14%
|
803
-21%
|
|
| Equity | ||||||||||||
| Common Stock |
18
|
18
|
18
|
18
|
21
|
146
|
146
|
146
|
146
|
146
|
521
|
|
| Retained Earnings |
63
|
65
|
69
|
81
|
157
|
240
|
267
|
345
|
314
|
250
|
239
|
|
| Total Equity |
81
N/A
|
83
+3%
|
88
+5%
|
99
+13%
|
178
+81%
|
385
+116%
|
413
+7%
|
491
+19%
|
460
-6%
|
395
-14%
|
760
+92%
|
|
| Total Liabilities & Equity |
527
N/A
|
596
+13%
|
594
0%
|
650
+10%
|
796
+22%
|
1 078
+35%
|
1 211
+12%
|
1 330
+10%
|
1 353
+2%
|
1 413
+4%
|
1 563
+11%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
15
|
15
|
15
|
15
|
2
|
15
|
15
|
15
|
15
|
17
|
24
|
|
Switch to:
Switch to:
See Also
Discover More
